Structure

InChI Key MXAYKZJJDUDWDS-LBPRGKRZSA-N
Smiles CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O
InChI
InChI=1S/C14H19BCl2N2O4/c1-8(2)5-12(15(22)23)19-13(20)7-18-14(21)10-6-9(16)3-4-11(10)17/h3-4,6,8,12,22-23H,5,7H2,1-2H3,(H,18,21)(H,19,20)/t12-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C14H19BCl2N2O4
Molecular Weight 361.03
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Bioactivity

Mechanism of Action Action Reference
26S proteasome inhibitor INHIBITOR EMA PubMed PubMed
Protein: 26S proteasome

Description: Proteasome subunit beta type-11

Organism : Homo sapiens

A5LHX3 ENSG00000222028
Protein: 26S proteasome

Description: 26S proteasome non-ATPase regulatory subunit 11

Organism : Homo sapiens

O00231 ENSG00000108671
Protein: 26S proteasome

Description: 26S proteasome non-ATPase regulatory subunit 12

Organism : Homo sapiens

O00232 ENSG00000197170
Protein: 26S proteasome

Description: Proteasome subunit alpha type-7

Organism : Homo sapiens

O14818 ENSG00000101182
Protein: 26S proteasome

Description: 26S proteasome non-ATPase regulatory subunit 3

Organism : Homo sapiens

O43242 ENSG00000108344
Protein: 26S proteasome

Description: 26S proteasome regulatory subunit 6A

Organism : Homo sapiens

P17980 ENSG00000165916
Protein: 26S proteasome

Description: Proteasome subunit beta type-1

Organism : Homo sapiens

P20618 ENSG00000008018
Protein: 26S proteasome

Description: Proteasome subunit alpha type-1

Organism : Homo sapiens

P25786 ENSG00000129084
Protein: 26S proteasome

Description: Proteasome subunit alpha type-2

Organism : Homo sapiens

P25787 ENSG00000106588
Protein: 26S proteasome

Description: Proteasome subunit alpha type-3

Organism : Homo sapiens

P25788 ENSG00000100567
Protein: 26S proteasome

Description: Proteasome subunit alpha type-4

Organism : Homo sapiens

P25789 ENSG00000041357
Protein: 26S proteasome

Description: Proteasome subunit beta type-8

Organism : Homo sapiens

P28062 ENSG00000204264
Protein: 26S proteasome

Description: Proteasome subunit beta type-9

Organism : Homo sapiens

P28065 ENSG00000240065
Protein: 26S proteasome

Description: Proteasome subunit alpha type-5

Organism : Homo sapiens

P28066 ENSG00000143106
Protein: 26S proteasome

Description: Proteasome subunit beta type-4

Organism : Homo sapiens

P28070 ENSG00000159377
Protein: 26S proteasome

Description: Proteasome subunit beta type-6

Organism : Homo sapiens

P28072 ENSG00000142507
Protein: 26S proteasome

Description: Proteasome subunit beta type-5

Organism : Homo sapiens

P28074 ENSG00000100804
Protein: 26S proteasome

Description: 26S proteasome regulatory subunit 7

Organism : Homo sapiens

P35998 ENSG00000161057
Protein: 26S proteasome

Description: Proteasome subunit beta type-10

Organism : Homo sapiens

P40306 ENSG00000205220
Protein: 26S proteasome

Description: 26S proteasome regulatory subunit 6B

Organism : Homo sapiens

P43686 ENSG00000013275
Protein: 26S proteasome

Description: 26S proteasome non-ATPase regulatory subunit 8

Organism : Homo sapiens

P48556 ENSG00000099341
Protein: 26S proteasome

Description: Proteasome subunit beta type-3

Organism : Homo sapiens

P49720 ENSG00000277791
Protein: 26S proteasome

Description: Proteasome subunit beta type-2

Organism : Homo sapiens

P49721 ENSG00000126067
Protein: 26S proteasome

Description: 26S proteasome non-ATPase regulatory subunit 7

Organism : Homo sapiens

P51665 ENSG00000103035
Protein: 26S proteasome

Description: 26S proteasome complex subunit SEM1

Organism : Homo sapiens

P60896 ENSG00000127922
Protein: 26S proteasome

Description: Proteasome subunit alpha type-6

Organism : Homo sapiens

P60900 ENSG00000100902
Protein: 26S proteasome

Description: 26S proteasome regulatory subunit 4

Organism : Homo sapiens

P62191 ENSG00000100764
Protein: 26S proteasome

Description: 26S proteasome regulatory subunit 8

Organism : Homo sapiens

P62195 ENSG00000087191
Protein: 26S proteasome

Description: 26S proteasome regulatory subunit 10B

Organism : Homo sapiens

P62333 ENSG00000100519
Protein: 26S proteasome

Description: 26S proteasome non-ATPase regulatory subunit 2

Organism : Homo sapiens

Q13200 ENSG00000175166
Protein: 26S proteasome

Description: 26S proteasome non-ATPase regulatory subunit 6

Organism : Homo sapiens

Q15008 ENSG00000163636
Protein: 26S proteasome

Description: Proteasomal ubiquitin receptor ADRM1

Organism : Homo sapiens

Q16186 ENSG00000130706
Protein: 26S proteasome

Description: Proteasome subunit alpha-type 8

Organism : Homo sapiens

Q8TAA3 ENSG00000154611
Protein: 26S proteasome

Description: Proteasome subunit beta type-7

Organism : Homo sapiens

Q99436 ENSG00000136930
Protein: 26S proteasome

Description: 26S proteasome non-ATPase regulatory subunit 1

Organism : Homo sapiens

Q99460 ENSG00000173692
Protein: 26S proteasome

Description: 26S proteasome non-ATPase regulatory subunit 13

Organism : Homo sapiens

Q9UNM6 ENSG00000185627
Assay Description Organism Bioactivity Reference
Reversible inhibition of human erythrocyte derived 20S proteasome subunit beta1 after 30 mins by fluorogenic assay Homo sapiens 31.0 nM
Reversible inhibition of human erythrocyte derived 20S proteasome subunit beta5 after 30 mins by fluorogenic assay Homo sapiens 3.4 nM
Inhibition of 20S proteasome beta5 subunit in human erythrocytes using Ac-WLA-AMC as substrate by fluorescence assay Homo sapiens 3.0 nM
Inhibition of 26S proteasome beta5 subunit in human Calu6 cells using Suc-LLVY-aminoluciferin as substrate after 1hr by luminescence assay Homo sapiens 9.0 nM
Inhibition of NFkappaB in HEK293 cells incubated for 1 hr prior to TNF-alpha challenge measured after 3 hrs by luciferase reporter gene assay relative to control Homo sapiens 6.2 nM
Inhibition of chymotrypsin-like activity of human 20S proteasome using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 10 mins followed by substrate addition measured after 1 hr by spectrofluorimetric method Homo sapiens 7.73 nM
Cytotoxicity against human RPMI8226 cells assessed as reduction in cell viability after 72 hrs by CellTiter 96 aqueous one solution assay Homo sapiens 55.32 nM
Cytotoxicity against human U266B1 cells assessed as reduction in cell viability after 72 hrs by CellTiter 96 aqueous one solution assay Homo sapiens 52.15 nM
Cytotoxicity against human ARH77 cells assessed as reduction in cell viability after 72 hrs by CellTiter 96 aqueous one solution assay Homo sapiens 65.5 nM
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging Homo sapiens 0.73 %
Inhibition of human 20S proteasome using Suc-LLVY-AMC as substrate measured every 5 mins for 120 mins by fluorescence based assay Homo sapiens 15.0 nM
Inhibition of 20S proteasome beta 1c (unknown origin) after 1 hr by fluorescence based assay Homo sapiens 3.0 nM
Inhibition of 20S proteasome beta 2c (unknown origin) after 1 hr by fluorescence based assay Homo sapiens 30.0 nM
Inhibition of 20S proteasome beta 5c (unknown origin) after 1 hr by fluorescence based assay Homo sapiens 3.4 nM
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 15.12 % SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 1.564 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 20.58 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 9.38 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 9.38 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 20.58 %

Cross References

Resources Reference
ChEBI 90942
ChEMBL CHEMBL2141296
DrugBank DB09570
DrugCentral 5067
FDA SRS 71050168A2
Guide to Pharmacology 8450
PDB 6V8
PubChem 25183872
SureChEMBL SCHEMBL3742758
ZINC ZINC000169946773